Jaguar Health Inc Share Price Nasdaq
Equities
US47008L1061
Biotechnology & Medical Research
Sales 2024 * | 15.11M 1.19B | Sales 2025 * | 22.66M 1.78B | Capitalization | 71.4M 5.62B |
---|---|---|---|---|---|
Net income 2024 * | -26M -2.05B | Net income 2025 * | -21M -1.65B | EV / Sales 2024 * | 4.73 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.15 x |
P/E ratio 2024 * |
-2.87
x | P/E ratio 2025 * |
-3.69
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.62% |
Latest transcript on Jaguar Health Inc
Managers | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 05/06/13 |
Carol Lizak
DFI | Director of Finance/CFO | 60 | 30/04/19 |
Chief Tech/Sci/R&D Officer | 60 | 30/04/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 05/06/13 |
James Bochnowski
CHM | Chairman | 80 | 31/01/14 |
John Micek
BRD | Director/Board Member | 71 | 31/03/16 |
1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |